Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- SCIB.ST
- Price
- 0.35
- Stock movement down
- -0.01 (-3.54%)
- Company name
- Scibase AB
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Medical Devices
- Market cap
- 146.62M
- Ent value
- 142.37M
- Price/Sales
- 4.01
- Price/Book
- 4.38
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -24.39%
- 1 year return
- 12.03%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-12-12
DIVIDENDS
SCIB.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 4.01 |
| Price to Book | 4.38 |
| EV to Sales | 3.89 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 414.18M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | -0.10 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 24.76M |
| Net receivables | 15.79M |
| Total current assets | 50.30M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 3.68M |
| Total assets | 53.98M |
| Accounts payable | 6.59M |
| Short/Current long term debt | 326.00K |
| Total current liabilities | 20.18M |
| Total liabilities | 20.50M |
| Shareholder's equity | 33.48M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.35 |
| Daily high | 0.37 |
| Daily low | 0.33 |
| Daily Volume | 282K |
| All-time high | 17.54 |
| 1y analyst estimate | 0.60 |
| Beta | 0.59 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 23 Feb 2026 |
Downside potential
Loading...
Downside potential data
| SCIB.ST | S&P500 | |
| Current price drop from All-time high | -97.98% | -1.08% |
| Highest price drop | -98.64% | -19.00% |
| Date of highest drop | 13 Nov 2025 | 8 Apr 2025 |
| Avg drop from high | -97.83% | -2.64% |
| Avg time to new high | - | 6 days |
| Max time to new high | 296 days | 89 days |
COMPANY DETAILS
Marketcap
146.62M
Marketcap category
Small-cap
Description
SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment. It has a collaboration with Mayo Clinic on pigmented lesion digital workflows with AI-driven Nevisense; Vrije Universiteit Brussel University hospitals for a study geared toward predicting atopic dermatitis and concomitant atopic diseases, such as asthma and hay fever in infants. SciBase Holding AB (publ) was founded in 1998 and is headquartered in Sundbyberg, Sweden.
Employees
38
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of AI-based diagnostic solutions for skin disorders, announces that it has been granted a new European patent, EP3876835B1 "Medical Devi...
December 11, 2025
SciBase Holding AB (publ) ("SciBase" or the "Company") publishes an information document in connection with the offer to repurchase all outstanding warrants of series TO 2 in SciBase (the "TO 2 Offer"...
December 5, 2025
Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance with the proposal presented in the notice to...
December 5, 2025
Alva Therapeutics, Inc. ("Alva") a company developing a novel oral incretin secretagogue based therapy for the treatment of Type 2 diabetes and obesity—announced that Mr. Jesper Høiland has been appoi...
December 3, 2025
The Board of Directors in SciBase Holding AB (publ) ("SciBase" or the "Company") has today resolved to make a repurchase offer for all 498,534,835 outstanding warrants of series TO 2 in the Company (t...
November 7, 2025
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced that SciBase and Castle Biosciences ("Castle") (NASDAQ: CSTL) have ...
November 7, 2025
The following people have been appointed as members of SciBase Holding's nominating committee for the Annual General Meeting in 2026:
October 22, 2025
SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, announced today the publication of a collaborative scientific project with the Swi...
September 26, 2025
SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that it has received the initial order for a clinical study under ...
September 23, 2025
SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that Ribbskottet AB, the company's largest owner, and Life Science...
September 10, 2025
Next page